Acid-Base Composition With Use of hemoDialysates
NCT02334267
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class
Conditions
End Stage Renal Disease
Interventions
DEVICE:
Group 1: GranuFlo
DEVICE:
Group 2: NaturaLyte
Sponsor
Fresenius Medical Care North America